NORDSON CORPORATION
At today's price, NORDSON CORPORATION (NDSN) is priced for +22.9% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
Nordson makes precision dispensing and fluid-control equipment across three segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. The business runs at a 26% operating margin and posted record first-quarter fiscal 2026 results, with sales up 9% and adjusted EPS up 15%, prompting a guidance raise. At $295.76 (June 27, 2026) the price pays about 25x company-wide operating income, which implies operating growth held at the self-funding ceiling for
Is NDSN overvalued? See what's priced in →
687 institutional managers reported holding NDSN in 13F filings for the quarter ended 2026-03-31. Together they hold about 72% of the company; the top 10 hold 38%. 77 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 1.4M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (3.8 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
NDSN has cut its share count 4% over the past five years, spending $852.28M on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting), raised 16 years straight; the current rate is $3.16 a share annually. Cash returned over the past three years: $508.04M in dividends and $504.35M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at NDSN over the trailing three years. Absence is a fact about the company, not a signal. 20 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
NDSN's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-25 | -0.3% | -11.1% |
| 2023-12-21 | +5.1% | +5.5% |
| 2024-02-23 | +3.5% | -4.9% |
| 2024-05-24 | -10.5% | +3.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
NDSN's latest 8-K filings: 2026-06-03 (items 2.03); 2026-05-20 (items 2.02, 7.01, 9.01); 2026-03-04 (items 5.07); 2026-02-18 (items 2.02, 7.01, 9.01); 2026-02-02 (items 1.01, 2.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.